APA (7th ed.) Citation

Eckardt, J., Bill, M., Rausch, C., Metzeler, K., Spiekermann, K., Stasik, S., . . . Röllig, C. (2023). Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification. Leukemia, 37(11), 2282. https://doi.org/10.1038/s41375-023-02016-6

Chicago Style (17th ed.) Citation

Eckardt, Jan-Niklas, et al. "Secondary-type Mutations Do Not Impact Outcome in NPM1-mutated Acute Myeloid Leukemia – Implications for the European LeukemiaNet Risk Classification." Leukemia 37, no. 11 (2023): 2282. https://doi.org/10.1038/s41375-023-02016-6.

MLA (9th ed.) Citation

Eckardt, Jan-Niklas, et al. "Secondary-type Mutations Do Not Impact Outcome in NPM1-mutated Acute Myeloid Leukemia – Implications for the European LeukemiaNet Risk Classification." Leukemia, vol. 37, no. 11, 2023, p. 2282, https://doi.org/10.1038/s41375-023-02016-6.